This was performed on a 1.5-T machine (Gyroscan, Powertrack 6000, Philips, Best, The Netherlands) by using a head-neck coil (Philips, Best, The Netherlands).
To the best of our knowledge, this is the first study to evaluate the HRQOL using a head and neck function specific measure in Turkish patients with head and neck cancer.
These findings support the concept of using a head and neck specific questionnaire as an indicator of oral function.
The region from the suprasellar cistern to the inferior margin of the sternal end of the clavicle was examined using a head and neck combined coil.
The area from the suprasellar cistern to the inferior margin of the sternal end of the clavicle was examined using a head and neck segregate coil.
The area from the suprasellar cistern to the inferior margin of the sternal end of the clavicle was examined using a head-and-neck combined coil.
MRI was performed using a 1.5-Tesla system (Signa CV/i; General Electric Healthcare, Chalfont St. Giles, United Kingdom) examining the area from the suprasellar cistern to the inferior margin of the sternal end of the clavicle using a head-and-neck combined coil.
We used a head and neck cancer (HNSCC) cell line, T-HEp3, which expresses high level of uPAR and α5β1-integrin, which by interacting are responsible for generating in vivo ERK activation and proliferative signal [2].
All MRI examinations were performed with a 1.5-T clinical imaging system (Gyroscan Intera®; Philips Medical Systems, Best, the Netherlands) using a synergy head neck coil.
The Siemens 16 CT Sensation machine was employed, using a tissue-equivalent head-neck radiotherapy humanoid phantom (Standard ATOM® Phantoms, CIRS, Norfolk, VA, USA) (Figures 1 and2).
